Dermapharm Holding SE buy Maxi_Scalibusa
Start price
23.04.19
/
50%
€31.50
Target price
04.11.21
€60.00
Performance (%)
184.60%
End price
05.11.21
€89.65
Summary
This prediction ended on 05.11.21 with a price of €89.65. The BUY prediction by Maxi_Scalibusa for Dermapharm Holding SE saw massive gains of 184.60%. Dividends of €1.57 are taken into consideration when calculating the performance. Maxi_Scalibusa has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -3.314% | -3.314% | 16.548% | -6.565% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Maxi_Scalibusa for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten